Conduent Inc (CNDT) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts such as insider buying and recognition in industry evaluations, the technical indicators are mixed, the financial performance shows declining revenue, and there is no strong proprietary trading signal or significant upward momentum. Given the user's preference for long-term investment, it is better to hold off on buying until clearer growth trends or stronger signals emerge.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 46.993, showing no clear overbought or oversold conditions. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5, suggesting a downward trend. The stock is trading below the pivot level of 1.504, with key support at 1.399 and resistance at 1.609.

Insiders are buying significantly, with a 133.40% increase in buying activity over the last month. The company has been recognized as a leader in NelsonHall's Healthcare Payer Agility & Innovation NEAT evaluation and named to the GovTech 100 list for the fifth consecutive year.
Despite improvements in net income and EPS, the overall financial performance still reflects a loss. Technical indicators and moving averages suggest a bearish trend.
In Q4 2025, revenue dropped to $770 million (-3.75% YoY). Net income improved to -$36 million (+140.00% YoY), and EPS increased to -0.23 (+155.56% YoY). Gross margin improved to 12.47% (+9.58% YoY), but the company is still operating at a loss.
No recent analyst ratings or price target changes are available for CNDT.
